CSL is interested in research developing novel therapeutic candidates or exploring novel drug targets for cardiovascular disease, with a particular focus on rare cardiovascular diseases. CSL has a high interest in engaging with academic research focusing on biologics as well as cell and gene therapies (including gene editing), with a particular interest in plasma-derived protein therapeutics.
In order to submit your available opportunities to these campaigns, please register to access your own dashboard from the links above. Once registered you will be able to submit opportunities to this campaign and stay updated about new campaigns from companies wishing to partner. For this campaign CSL have requested you provide a one-page summary of your opportunity, as well as any publicly available information on additional documents.